Bozkaya Halil, Cinar Celal, Ertugay Serkan, Korkmaz Mehmet, Guneyli Serkan, Posacioglu Hakan, Parıldar Mustafa
Division of Interventional Radiology, Department of Radiology, Ege University, School of Medicine, Izmir, Turkey.
Department of Cardiovascular Surgery, Ege University, School of Medicine, Izmir, Turkey.
Ann Vasc Dis. 2015;8(1):21-8. doi: 10.3400/avd.oa.14-00110. Epub 2015 Feb 16.
May-Thurner syndrome (MTS) is a rare clinical entity featuring venous obstruction of the left lower extremity. The aim of the present study was to report our experience with MTS and to evaluate the utility of treatment using endovascular techniques.
We retrospectively analyzed data on 23 MTS patients (21 females, two males; mean age 44 ± 15 years). Eighteen patients presented with deep vein thrombosis (DVT) and five with symptoms associated with chronic venous hypertension (CVH). DVT patients were treated via thromboaspiration, catheter-directed thrombolysis, and angioplasty; followed by stent placement. CVH patients were treated with angioplasty and stent placement alone. All patients were followed-up using Doppler ultrasonography and computed tomography venography.
Complete left common iliac vein patency was achieved in 21 of the 23 patients (technical success rate: 91,3%). Complete thrombolysis was attained by 14 of the 18 DVT patients (77.7%). The mean clinical and radiological follow-up time was 15.2 ± 16.1 months. Upon follow-up, complete symptomatic regression was observed in 19 of the 23 patients (82.6%). Stent patency was complete in 19 of the 21 patients (90.4%) who received stents. Restenosis occurred in two patients. No treatment-related mortality or morbidity was observed.
Endovascular treatment of MTS is safe and effective and reduces symptoms in most patients, associated with high medium-term patency rates.
May-Thurner综合征(MTS)是一种罕见的临床病症,其特征为左下肢静脉阻塞。本研究的目的是报告我们治疗MTS的经验,并评估血管内技术治疗的效用。
我们回顾性分析了23例MTS患者(21例女性,2例男性;平均年龄44±15岁)的数据。18例患者表现为深静脉血栓形成(DVT),5例有与慢性静脉高压(CVH)相关的症状。DVT患者通过血栓抽吸、导管直接溶栓和血管成形术进行治疗;随后进行支架置入。CVH患者仅接受血管成形术和支架置入治疗。所有患者均使用多普勒超声和计算机断层静脉造影进行随访。
23例患者中有21例实现了左髂总静脉完全通畅(技术成功率:91.3%)。18例DVT患者中有14例实现了完全溶栓(77.7%)。临床和影像学平均随访时间为15.2±16.1个月。随访时,23例患者中有19例(82.6%)症状完全消退。接受支架置入的21例患者中有19例(90.4%)支架通畅。2例患者发生再狭窄。未观察到与治疗相关的死亡率或发病率。
MTS的血管内治疗安全有效,可减轻大多数患者的症状,且中期通畅率高。